NISHIOKA Chie 西岡千惠

Researcher Number	40707147
Affiliation (based on the past Project Information) *help	2015 – 2016: 高知大学, 医学部, 特任助教 2014: 高知大学, 教育研究部・医療学系, 研究員
Review Section/Research Field	Principal Investigator Hematology
Keywords	Principal Investigator EZH2 / 急性骨髄性白血病 / DNMT3A / STAT5 / microRNA / E-cadherin / IL-10 / AraC / BCL2L12 / leukemia / CD82

Research Projects
(1 results)
Research Products
(8 results)

Fundamental medical research to establish treatment of leukemia as targeting CD82Principal Investigator
- Principal Investigator
  
  NISHIOKA Chie
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Hematology
- Research Institution
  Kochi University

All 2017 2016 2015

All Journal Article Presentation

[Journal Article] miR-9 plays a role in IL-10-mediated expression of E-cadherin in acute myelogenous leukemia cells.2017
- Author(s)
  Nishioka C
- Journal Title
  
  Cancer Science
  
  Volume: 印刷中 Issue: 4 Pages: 685-695
- DOI
  10.1111/cas.13170
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26860736
[Journal Article] 治療抵抗性急性骨髄性白血病におけるCD82発現の意義2016
- Author(s)
  西岡千惠、池添隆之
- Journal Title
  
  血液内科
  
  Volume: 72 Pages: 386-91
- NAID
  40020862964
- Data Source
  KAKENHI-PROJECT-26860736
[Journal Article] STAT5A regulates DNMT3A in CD34(+)/CD38(-) AML cells.2015
- Author(s)
  Takeuchi A, Nishioka C, Ikezoe T, Yang J, Yokoyama A.
- Journal Title
  
  Leuk Res.
  
  Volume: 39 Issue: 8 Pages: 897-905
- DOI
  10.1016/j.leukres.2015.05.006
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26860736
[Journal Article] Blockade of CD82 by a monoclonal antibody potentiates anti-leukemia effects of AraC in vivo.2015
- Author(s)
  Nishioka C, Ikezoe T, Yokoyama A.
- Journal Title
  
  Cancer Med.
  
  Volume: 4 Issue: 9 Pages: 1426-31
- DOI
  10.1002/cam4.482
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26860736
[Journal Article] Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.2015
- Author(s)
  Nishioka C, Ikezoe T, Yang J, Yokoyama A.
- Journal Title
  
  Plos one
  
  Volume: 10
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26860736
[Journal Article] The novel function of CD82 and its impact on BCL2L12 via AKT/STAT5 signal pathway in acute myelogenous leukemia cells.2015
- Author(s)
  Nishioka C, Ikezoe T, Takeuchi A, Nobumoto A, Tsuda M, Yokoyama A.
- Journal Title
  
  Leukemia
  
  Volume: 29 Issue: 12 Pages: 2296-306
- DOI
  10.1038/leu.2015.219
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26860736
[Presentation] miR-9 plays a role in IL-10-mediated expression of E-cadherin in acute myelogenous leukemia cells.2016
- Author(s)
  Chie Nishioka, Takayuki Ikezoe, Akihito Yokoyama.
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜(神奈川県横浜市)
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26860736
[Presentation] Blockade of CD82 by a monoclonal antibody potentiates anti-leukemia effects of AraC in vivo.2015
- Author(s)
  Chie Nishioka, Takayuki Ikezoe, Akihito Yokoyama.
- Organizer
  第74回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場（愛知県名古屋市）
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-26860736

NISHIOKA Chie 西岡 千惠

Research Projects

Research Products

Fundamental medical research to establish treatment of leukemia as targeting CD82Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] miR-9 plays a role in IL-10-mediated expression of E-cadherin in acute myelogenous leukemia cells.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 治療抵抗性急性骨髄性白血病におけるCD82発現の意義2016

Author(s)

Journal Title

NAID

Data Source

[Journal Article] STAT5A regulates DNMT3A in CD34(+)/CD38(-) AML cells.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Blockade of CD82 by a monoclonal antibody potentiates anti-leukemia effects of AraC in vivo.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.2015

Author(s)

Journal Title

Data Source

[Journal Article] The novel function of CD82 and its impact on BCL2L12 via AKT/STAT5 signal pathway in acute myelogenous leukemia cells.2015

Author(s)

Journal Title

DOI

Data Source

[Presentation] miR-9 plays a role in IL-10-mediated expression of E-cadherin in acute myelogenous leukemia cells.2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Blockade of CD82 by a monoclonal antibody potentiates anti-leukemia effects of AraC in vivo.2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

NISHIOKA Chie 西岡千惠